Covered recipient · General Payments record
ROBERT M TREPEL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology
General Payments · PY2019–2023
$499.51
- Reported across 19 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.96 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $105.35 | 5 |
| Supernus Pharmaceuticals, Inc. | $91.10 | 4 |
| UCB, Inc. | $71.78 | 3 |
| Neos Therapeutics, LP | $51.40 | 3 |
| Evofem Biosciences, Inc. | $36.33 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $20.64 | 02/13/2023 | Food and Beverage | Undisputed | 06/30/2026 | 978072223 | CMS |
| Corium, LLC | $19.80 | 04/03/2023 | Food and Beverage | Undisputed | 06/30/2026 | 978218037 | CMS |
| Corium, LLC | $21.75 | 07/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 978538777 | CMS |
| Corium, LLC | $22.23 | 09/12/2023 | Food and Beverage | Undisputed | 06/30/2026 | 978389755 | CMS |
| Corium, LLC | $20.93 | 09/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 978389765 | CMS |
| Evofem Biosciences, Inc. | $16.96 | 10/01/2023 | Food and Beverage | Undisputed | 06/30/2026 | 976101209 | CMS |
| Evofem Biosciences, Inc. | $19.37 | 10/26/2023 | Food and Beverage | Undisputed | 06/30/2026 | 976101213 | CMS |
| Neos Therapeutics, LP | $18.01 | 09/21/2023 | Food and Beverage | Undisputed | 06/30/2026 | 984544737 | CMS |
| Neos Therapeutics, LP | $18.01 | 10/16/2023 | Food and Beverage | Undisputed | 06/30/2026 | 984548657 | CMS |
| Neos Therapeutics, LP | $15.38 | 11/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 984556509 | CMS |
| Supernus Pharmaceuticals, Inc. | $16.24 | 03/20/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053318159 | CMS |
| Supernus Pharmaceuticals, Inc. | $12.83 | 08/08/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053318163 | CMS |
| Supernus Pharmaceuticals, Inc. | $47.65 | 09/06/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053318167 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.38 | 10/30/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053318171 | CMS |
| UCB, Inc. | $26.24 | 01/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1021772377 | CMS |
| UCB, Inc. | $18.73 | 02/09/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1021772371 | CMS |
| UCB, Inc. | $26.81 | 08/21/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1021772383 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2019 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.